These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

313 related articles for article (PubMed ID: 23442079)

  • 1. Noninvasive insulin delivery: the great potential of cell-penetrating peptides.
    Kamei N; Nielsen EJ; Khafagy el-S; Takeda-Morishita M
    Ther Deliv; 2013 Mar; 4(3):315-26. PubMed ID: 23442079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. One-month subchronic toxicity study of cell-penetrating peptides for insulin nasal delivery in rats.
    Khafagy el-S; Kamei N; Nielsen EJ; Nishio R; Takeda-Morishita M
    Eur J Pharm Biopharm; 2013 Nov; 85(3 Pt A):736-43. PubMed ID: 24060698
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral biodrug delivery using cell-penetrating peptide.
    Khafagy el-S; Morishita M
    Adv Drug Deliv Rev; 2012 May; 64(6):531-9. PubMed ID: 22245080
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of a non-covalent cell-penetrating peptide strategy to enhance the nasal delivery of interferon beta and its PEGylated form.
    Iwase Y; Kamei N; Khafagy el-S; Miyamoto M; Takeda-Morishita M
    Int J Pharm; 2016 Aug; 510(1):304-10. PubMed ID: 27343364
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo proof of concept of oral insulin delivery based on a co-administration strategy with the cell-penetrating peptide penetratin.
    Nielsen EJ; Yoshida S; Kamei N; Iwamae R; Khafagy el-S; Olsen J; Rahbek UL; Pedersen BL; Takayama K; Takeda-Morishita M
    J Control Release; 2014 Sep; 189():19-24. PubMed ID: 24973720
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Exploration of the Key Factors for Optimizing the in Vivo Oral Delivery of Insulin by Using a Noncovalent Strategy with Cell-Penetrating Peptides.
    Kamei N; Shigei C; Hasegawa R; Takeda-Morishita M
    Biol Pharm Bull; 2018; 41(2):239-246. PubMed ID: 29386483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Nose-to-Brain Delivery of Peptide Drugs Enhanced by Coadministration of Cell-penetrating Peptides: Therapeutic Potential for Dementia].
    Kamei N
    Yakugaku Zasshi; 2017; 137(10):1247-1253. PubMed ID: 28966266
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular imaging analysis of intestinal insulin absorption boosted by cell-penetrating peptides by using positron emission tomography.
    Kamei N; Morishita M; Kanayama Y; Hasegawa K; Nishimura M; Hayashinaka E; Wada Y; Watanabe Y; Takayama K
    J Control Release; 2010 Aug; 146(1):16-22. PubMed ID: 20457194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of different intestinal conditions on the intermolecular interaction between insulin and cell-penetrating peptide penetratin and on its contribution to stimulation of permeation through intestinal epithelium.
    Kamei N; Aoyama Y; Khafagy el-S; Henmi M; Takeda-Morishita M
    Eur J Pharm Biopharm; 2015 Aug; 94():42-51. PubMed ID: 25960330
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brain delivery of insulin boosted by intranasal coadministration with cell-penetrating peptides.
    Kamei N; Takeda-Morishita M
    J Control Release; 2015 Jan; 197():105-10. PubMed ID: 25445695
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overcoming the diffusion barrier of mucus and absorption barrier of epithelium by self-assembled nanoparticles for oral delivery of insulin.
    Shan W; Zhu X; Liu M; Li L; Zhong J; Sun W; Zhang Z; Huang Y
    ACS Nano; 2015 Mar; 9(3):2345-56. PubMed ID: 25658958
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanistic study of the uptake/permeation of cell-penetrating peptides across a caco-2 monolayer and their stimulatory effect on epithelial insulin transport.
    Kamei N; Onuki Y; Takayama K; Takeda-Morishita M
    J Pharm Sci; 2013 Nov; 102(11):3998-4008. PubMed ID: 23963728
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhaled insulin-intrapulmonary, intranasal, and other routes of administration: mechanisms of action.
    Henkin RI
    Nutrition; 2010 Jan; 26(1):33-9. PubMed ID: 20005465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Penetratin derivative-based nanocomplexes for enhanced intestinal insulin delivery.
    Zhu X; Shan W; Zhang P; Jin Y; Guan S; Fan T; Yang Y; Zhou Z; Huang Y
    Mol Pharm; 2014 Jan; 11(1):317-28. PubMed ID: 24255985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-penetrating peptides as tools to enhance non-injectable delivery of biopharmaceuticals.
    Kristensen M; Nielsen HM
    Tissue Barriers; 2016; 4(2):e1178369. PubMed ID: 27358757
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Visualization and Quantitative Assessment of the Brain Distribution of Insulin through Nose-to-Brain Delivery Based on the Cell-Penetrating Peptide Noncovalent Strategy.
    Kamei N; Shingaki T; Kanayama Y; Tanaka M; Zochi R; Hasegawa K; Watanabe Y; Takeda-Morishita M
    Mol Pharm; 2016 Mar; 13(3):1004-11. PubMed ID: 26795701
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Region-Dependent Role of Cell-Penetrating Peptides in Insulin Absorption Across the Rat Small Intestinal Membrane.
    Khafagy el-S; Iwamae R; Kamei N; Takeda-Morishita M
    AAPS J; 2015 Nov; 17(6):1427-37. PubMed ID: 26216471
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficiency of cell-penetrating peptides on the nasal and intestinal absorption of therapeutic peptides and proteins.
    Khafagy el-S; Morishita M; Kamei N; Eda Y; Ikeno Y; Takayama K
    Int J Pharm; 2009 Oct; 381(1):49-55. PubMed ID: 19646515
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of cell-penetrating peptides on the nasal absorption of insulin.
    Khafagy el-S; Morishita M; Isowa K; Imai J; Takayama K
    J Control Release; 2009 Jan; 133(2):103-8. PubMed ID: 18930084
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Improvement of intestinal absorption of peptide and protein drugs by chemical modification with fatty acids].
    Yamamoto A
    Nihon Rinsho; 1998 Mar; 56(3):601-7. PubMed ID: 9549343
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.